||AIM: The aim of Miguel Castanho Lab is to unravel the physical principles that determine peptide/protein-lipid interactions, with implications in viral fusion (eg HIV, Dengue, Zika, Measles), antimicrobial action, including biofilms, and CNS-targeting (translocation of the blood-brain barrier, BBB, in analgesia and neuroprotection). ||MAIN PARADIGM-SHIFT ACHIEVEMENTS AND DISRUPTIVE LINES OF WORK: > Viral fusion – We established that viral fusion inhibitors for HIV and Measles interact with membranes as part of their mode of action and self-association events are key for their efficacy (eg JACS 2004, 126, 14758-14763; JACS 2008, 130, 6215-6223; J Virol 2017, 91, e01554-16; ACS Nano 2018, 12, 9855-9865). | > Translocation over the BBB – Cell penetrating peptides from viral protein domain templates that use receptor-free routes are now used as efficient carriers to shuttle drugs and antibodies to the brain (eg Biochemistry 2005, 44, 10189-10198; Bioinformatics 2015, 31, 2252-2256; ACS Chemical Biology 2017, 12, 1257-1268). | > Antibacterial action – We bridged molecular biophysics of antimicrobial peptides studies in artificial systems to microbiology as we found how to quantitatively estimate biological activity from biophysical parameters (eg Biochimica et Biophysica Acta -Biomembranes 2007, 1768, 1277-1290; Nature Reviews Microbiology 2009, 7, 245-250; J Biol Chem 2010, 285, 27536-27544; J Antimicrobial Chemotherapy 2019, dkz223). | > Analgesia and neuroprotection – Endogenous neuropeptides were modified so they could traverse the BBB and be used in analgesia and neuroprotection therapies (eg British J Pharmacol 2011, 163, 964-973; Molecular pharmaceutics 2011, 1929-1940; Frontiers in aging neuroscience 2013, 5, 68; ACS Chemical Neuroscience 2017, 8, 1663-1667). | > Quantifying and imaging drug-lipid interactions – We have developed tailored methodologies based on spectroscopic techniques, such as fluorescence emission, SPR, and light scattering with zeta-potential, and AFM to quantify retention of drugs in lipid structures and unravel the structures emerging therefrom (eg Analytical Biochemistry 2002,307, 1-12; BBA-Biomembranes 2003; 1612; 123-135; Trends Pharm Sciences 2010, 31, 449-454; Eur Biophys J 2011, 40, 481-487; BBA-Biomembranes 2015, 1848, 554-560; Frontiers in microbiology 2017, 8, 775). ||TRANSLATION TO INDUSTRY: Encompassing the achievements in academic research, Castanho’s lab has engaged with industry for drug development in the fields of Pain (2 patents), neuroprotection (2 patents), and viral infection (1 patent). 3 out of the 5 patents were filed under agreement with industrial partners. | M Castanho coordinated the consortia of 2 major academia-industry projects funded by the EU. Currently, he coordinates an EIC (European Innovation Council) FET-OPEN academia-industry consortium for antiviral drug development. ||SERVICE TO SOCIETY M Castanho, among other appointments, has been the president of the Portuguese Biochemical Society, and member of working groups in FEBS and PABMB. He has also contributed to the organization of major international meetings (eg FEBS2012, 14th IUBMB Conference, Chairman of the IUBMB-FEBS-PABMB 2021 congress). In addition, he contributes regularly to the general press and mass media with opinion articles as advocate for Science. | Chief Editor for Pharmaceutical Innovations/Frontiers in Medical Technologies, and editorial board member of J. Peptide Sci, and Peptide Sci. || INVITATIONS TO MAJOR INTERNATIONAL MEETINGS: Invited plenary/keynote speaker for major international meetings in Biophysics and Peptide Science, such as: 33rd European Peptide Symposium, 22nd American Peptide Symposium, 9th European Biophysics Congress. ||BIBLIOMETRIC DATA March 2020: 178 papers in international prestige journals, H= 40-46, 5 books as main co-editor. Remark: poster and short oral communications not listed totally below to avoid the burden of information overload

Identificação pessoal

Nome completo
Miguel Castanho

Nomes de citação

  • Castanho, Miguel

Identificadores de autor

Ciência ID


  • Faculty of Medicine - Institute of Molecular Medicine and Biochemistry Department, University of Lisbon. , School of Medicine, Edifício Egas Moniz, 1649-028, Lisboa, Lisboa, Portugal (Profissional)


Domínios de atuação

  • Ciências Médicas e da Saúde - Ciências da Saúde
  • Ciências Naturais - Ciências Biológicas - Biofísica
  • Ciências Sociais - Ciências da Comunicação
  • Ciências Médicas e da Saúde - Ciências da Saúde
  • Ciências Médicas e da Saúde - Ciências da Saúde
  • Ciências Médicas e da Saúde - Ciências da Saúde
Grau Classificação
Título de Agregado (Título de Agregado)
Universidade de Lisboa Faculdade de Ciências, Portugal
Cum laude
Bioquímica Física / Biofísica Molecular / Química Biofísica (Doutoramento)
Universidade de Lisboa Instituto Superior Técnico, Portugal
"A model for the biochemical action of the antibiotic Filipin" (TESE/DISSERTAÇÃO)
Cum laude
Biochemistry (Licenciatura)
Universidade de Lisboa Faculdade de Ciências, Portugal
"Interacção polienos-colesterol em bicamadas lipídicas" (TESE/DISSERTAÇÃO)
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento
2007/09/01 - Atual Professor Catedrático (Docente Universitário) Universidade de Lisboa Faculdade de Medicina, Portugal
2002/05/15 - 2007/08/31 Professor Associado (Docente Universitário) Universidade de Lisboa Faculdade de Ciências, Portugal
1994/11/15 - 2002/05/15 Professor Auxiliar (Docente Universitário) Universidade de Lisboa Faculdade de Ciências, Portugal


Categoria Profissional
Instituição de acolhimento
2007/09/01 - Atual Director - Institute of Biochemistry, Faculty of Medicine, University of Lisbon. Universidade de Lisboa Faculdade de Medicina, Portugal
2016/02/10 - 2017/09/14 Vice-President Fundação para a Ciência e a Tecnologia, Portugal
2011/08/10 - 2016/02/10 Vice-dean Universidade de Lisboa Faculdade de Medicina, Portugal
2006/01/01 - 2007/08/31 Vice-president - Scientific Council - Faculty of Sciences, Univ. Lisbon Universidade de Lisboa Faculdade de Ciências, Portugal


Designação Financiadores
2022/01/01 - 2025/12/31 BREAST-BRAIN-N-BBB: Protecting the brain from metastatic breast cancer.
Grant HR21-00605
Investigador responsável
Instituto de Medicina Molecular, Portugal

CIC biomaGUNE, Espanha

Biodonostia Instituto de Investigación Sanitaria, Espanha

Universidade de Lisboa Faculdade de Farmácia, Portugal
Obra Social La Caixa

Fundação para a Ciência e a Tecnologia
Em curso
2019 - 2024 NOVIRUSES2BRAIN: ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individual
Investigador responsável
Instituto de Medicina Molecular, Portugal
Horizon 2020 European Innovation Council Fast Track to Innovation
Em curso
2014 - 2021 M2b-PhD: A multinstitutional doctoral program on Medical Biochemistry and Biophysics
Investigador responsável
Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2017/10/02 - 2019 Cell-cell communication in metastatic breast cancer: a control point that can lead to breast cancer treatment
Investigador responsável
Fundação para a Ciência e a Tecnologia
2015 - 2019 INPACT: Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication
Proposal number: 644167
Investigador responsável
Instituto de Medicina Molecular, Portugal
Research Executive Agency
2015/02/01 - 2018 Engineering protease-resistant alpha-beta peptides for broad-spectrum antivirals
Instituto de Medicina Molecular, Portugal
National Institutes of Health
2014/03 - 2017/02 DELIN: An innovative approach to deliver dual-targeting HIV entry inhibitors using cationic liposomes
Investigador responsável
Instituto de Medicina Molecular, Portugal
Fundação para a Ciência e a Tecnologia, I.P.
2011 - 2015 PPS3 - Peptides and antibodies in Alzheimer research
Investigador responsável
2011/03 - 2014/08 Membrane fusion mechanism of Influenza Hemagglutinin: a simulation and biophysical approach.
Instituto de Medicina Molecular, Portugal
Fundação para a Ciência e a Tecnologia, I.P.
2011/03 - 2014/08 LIPIDENGUE: The role of hepatic lipid membranes and lipid droplets in Dengue virus encapsidation. A gateway to new therapies.
Investigador responsável
Instituto de Medicina Molecular, Portugal
Fundação para a Ciência e a Tecnologia, I.P.
2009 - 2013 PEP2BRAIN: Selected peptides as drug candidates directed to pain and neurodegeneration
Investigador responsável
Research Executive Agency
2009/01/01 - 2012 Elucidating the mechanism of action of cyclotides: ultra-stable proteins from plants
Investigador responsável
European Commission
2009 - 2012 MEMPEPACROSS: Membrane-active peptides across disciplines and continents: An integrated approach to find new strategies to fight bacteria, dengue virus and neurodegeneration
Investigador responsável
2007/09 - 2011/01 Targeting effective kyotorphin derivatives to the brain Fundação para a Ciência e a Tecnologia, I.P.
2008 - 2011 Unravelling the mechanism of action of membrane-active peptides combining NMR and optical spectroscopies
2008 - 2011 Project 4.1.3/CAPES/CPLP joint project with the Lab. Biochemistry of Virus, Federal University Rio de Janeiro, Brazil
Investigador responsável
2005 - 2008 An atomic force microscopy facility devoted to biomedical and biochemical studies at the molecular-level
Project REEQ/140/BIO/2005
Investigador responsável
1998 - 2001 The interaction of the fusion peptide of the HIV-1 membrane protein, gp41, with biomembranes and its inhibition
Investigador responsável
1998 - 2001 Structural details of the mode of action of the fusion peptide of the HIV-1 membrane protein gp41 and its analogues
Investigador responsável
1996 - 1999 Structural study of the interaction between Influenza´s Haemagglutinin and a peptide derived from gp41 (HIV-1) with model systems of membranes
Investigador responsável


Designação Financiadores
2019 - 2023 VectorB2B: Drug Developing - new company gathering strengths, building capacity, innovating products, and far fetching in Drug Discovery and Development services
Investigador responsável
Universidade de Lisboa Faculdade de Medicina, Portugal

TechnoPhage SA, Portugal

Universidade de Coimbra, Portugal

Universidade de Lisboa Faculdade de Farmácia, Portugal

Universidade de Lisboa Instituto Superior Técnico, Portugal

Universidade do Porto, Portugal
Fundação para a Ciência e a Tecnologia
Em curso


Artigo em revista
  1. Mota-Silva, Iara; Castanho, Miguel A. R. B.; Silva-Herdade, Ana Santos. "Towards Non-Invasive Intravital Microscopy: Advantages of Using the Ear Lobe Instead of the Cremaster Muscle". Life 13 4 (2023): 887. http://dx.doi.org/10.3390/life13040887.
  2. André, Ana S.; Dias, Joana N. R.; Aguiar, Sandra; Nogueira, Sara; Bule, Pedro; Carvalho, Joana Inês; António, João P. M.; et al. "Rabbit derived VL single-domains as promising scaffolds to generate antibody–drug conjugates". Scientific Reports 13 1 (2023): http://dx.doi.org/10.1038/s41598-023-31568-x.
  3. Vieira-da-Silva, Beatriz; Castanho, Miguel A. R. B.. "Resazurin Reduction-Based Assays Revisited: Guidelines for Accurate Reporting of Relative Differences on Metabolic Status". Molecules 28 5 (2023): 2283. http://dx.doi.org/10.3390/molecules28052283.
  4. Strandberg, Erik; Wadhwani, Parvesh; Bürck, Jochen; Anders, Patrick; Mink, Christian; van den Berg, Jonas; Ciriello, Raffaele A. M.; et al. "Temperature-Dependent Re-alignment of the Short Multifunctional Peptide BP100 in Membranes Revealed by Solid-State NMR Spectroscopy and Molecular Dynamics Simulations". ChemBioChem 24 4 (2023): http://dx.doi.org/10.1002/cbic.202200602.
  5. Vieira-da-Silva, Beatriz; Castanho, Miguel A. R. B.. "The structure and matrix dynamics of bacterial biofilms as revealed by antimicrobial peptides' diffusion". Journal of Peptide Science (2023): http://dx.doi.org/10.1002/psc.3470.
  6. Sousa, Bárbara B.; de Almeida, Cátia Rebelo; Barahona, Ana F.; Lopes, Raquel; Martins-Logrado, Ana; Cavaco, Marco; Neves, Vera; et al. "Selective Inhibition of Bruton’s Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors". ACS Pharmacology & Translational Science 5 11 (2022): 1156-1168. http://dx.doi.org/10.1021/acsptsci.2c00163.
  7. Dias, Susana A; Pinto, Sandra N; Silva-Herdade, Ana S; Cheneval, Olivier; Craik, David J; Coutinho, Ana; Castanho, Miguel A R B; Henriques, Sónia T; Veiga, Ana Salomé. "A designed cyclic analogue of gomesin has potent activity against Staphylococcus aureus biofilms". Journal of Antimicrobial Chemotherapy 77 12 (2022): 3256-3264. http://dx.doi.org/10.1093/jac/dkac309.
  8. Valério, Mariana; Mendonça, Diogo A.; Morais, João; Buga, Carolina C.; Cruz, Carlos H.; Castanho, Miguel A.R.B.; Melo, Manuel N.; et al. "Parainfluenza Fusion Peptide Promotes Membrane Fusion by Assembling into Oligomeric Porelike Structures". ACS Chemical Biology 17 7 (2022): 1831-1843. http://dx.doi.org/10.1021/acschembio.2c00208.
  9. Todorovski, Toni; Mendonça, Diogo A.; Fernandes-Siqueira, Lorena O.; Cruz-Oliveira, Christine; Guida, Giuseppina; Valle, Javier; Cavaco, Marco; et al. "Targeting Zika Virus with New Brain- and Placenta-Crossing Peptide–Porphyrin Conjugates". Pharmaceutics 14 4 (2022): 738. http://dx.doi.org/10.3390/pharmaceutics14040738.
  10. Cavaco, Marco; Castanho, Miguel A. R. B.; Neves, Vera. "The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections". Frontiers in Microbiology 13 (2022): http://dx.doi.org/10.3389/fmicb.2022.835677.
  11. Caccuri, Francesca; Neves, Vera; Gano, Lurdes; Correia, João D. G.; Oliveira, Maria Cristina; Mazzuca, Pietro; Caruso, Arnaldo; Castanho, Miguel. "The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier". Journal of Virology 96 1 (2022): http://dx.doi.org/10.1128/jvi.01200-21.
  12. Marco Cavaco; Silvia Frutos; Paula Oliete; Javier Valle; David Andreu; Miguel A. R. B. Castanho; Miquel Vila-Perelló; Vera Neves. "Conjugation of a Blood Brain Barrier Peptide Shuttle to an Fc Domain for Brain Delivery of Therapeutic Biomolecules". ACS Medicinal Chemistry Letters (2021): https://doi.org/10.1021/acsmedchemlett.1c00225.
  13. Oliveira, Filipa D.; Cavaco, Marco; Figueira, Tiago N.; Valle, Javier; Neves, Vera; Andreu, David; Gaspar, Diana; Castanho, Miguel A. R. B.. "The antimetastatic breast cancer activity of the viral protein-derived peptide vCPP2319 as revealed by cellular biomechanics". The FEBS Journal 289 6 (2021): 1603-1624. http://dx.doi.org/10.1111/febs.16247.
  14. Cavaco, Marco; Fraga, Patrícia; Valle, Javier; Andreu, David; Castanho, Miguel A. R. B.; Neves, Vera. "Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide". Pharmaceutics 13 11 (2021): 1863. http://dx.doi.org/10.3390/pharmaceutics13111863.
  15. Oliveira, Filipa D.; Castanho, Miguel A. R. B.; Neves, Vera. "Exosomes and Brain Metastases: A Review on Their Role and Potential Applications". International Journal of Molecular Sciences 22 19 (2021): 10899. http://dx.doi.org/10.3390/ijms221910899.
  16. Sandra Isabel Aguiar; Joana N. R. Dias; Ana André; Marta Lisete Silva; Diana Martins; Belmira Carrapiço; Miguel Castanho; et al. "Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening". Pharmaceutics 13 10 (2021): 1598. https://www.mdpi.com/1999-4923/13/10/1598.
  17. Mink, Christian; Strandberg, Erik; Wadhwani, Parvesh; Melo, Manuel N.; Reichert, Johannes; Wacker, Irene; Castanho, Miguel A. R. B.; Ulrich, Anne S.. "Overlapping Properties of the Short Membrane-Active Peptide BP100 With (i) Polycationic TAT and (ii) a-helical Magainin Family Peptides". Frontiers in Cellular and Infection Microbiology 11 (2021): http://dx.doi.org/10.3389/fcimb.2021.609542.
  18. Gallo, Maria; Moreno, Estefanía; Defaus, Sira; Ortega-Alvaro, Antonio; Gonzalez, Angel; Robledo, Patricia; Cavaco, Marco; et al. "Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects". Journal of Medicinal Chemistry 64 10 (2021): 6937-6948. http://dx.doi.org/10.1021/acs.jmedchem.1c00484.
  19. Cavaco, Marco; Valle, Javier; Flores, Isabel; Andreu, David; A. R. B. Castanho, Miguel. "Estimating peptide half-life in serum from tunable, sequence-related physicochemical properties". Clinical and Translational Science (2021): http://dx.doi.org/10.1111/cts.12985.
  20. Marco Cavaco; David Andreu; Miguel A. R. B. Castanho. "The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization". Angewandte Chemie (2021): https://doi.org/10.1002/ange.202006372.
  21. Cadima-Couto, Iris; Tauzin, Alexandra; Freire, João M.; Figueira, Tiago N.; Silva, Rúben D. M.; Pérez-Peinado, Clara; Cunha-Santos, Catarina; et al. "Anti-HIV-1 Activity of pepRF1, a Proteolysis-Resistant CXCR4 Antagonist Derived from Dengue Virus Capsid Protein". ACS Infectious Diseases 7 1 (2020): 6-22. http://dx.doi.org/10.1021/acsinfecdis.9b00507.
  22. Ana Silva Herdade; Iara Mota Silva; Ângelo Calado; Carlota Saldanha; Ngan-Ha Nguyen; Isabella Hou; Miguel Castanho; Sayon Roy. "Effects of Diabetes on Microcirculation and Leukostasis in Retinal and Non-Ocular Tissues: Implications for Diabetic Retinopathy". Biomolecules (2020): https://doi.org/10.3390/biom10111583.
  23. Lousa, Diana; Pinto, Antónia R. T.; Campos, Sara R. R.; Baptista, António M.; Veiga, Ana S.; Castanho, Miguel A. R. B.; Soares, Cláudio M.. "Effect of pH on the influenza fusion peptide properties unveiled by constant-pH molecular dynamics simulations combined with experiment". Scientific Reports 10 1 (2020): http://dx.doi.org/10.1038/s41598-020-77040-y.
  24. de Almeida Fuzeta, Miguel; Bernardes, Nuno; Oliveira, Filipa D.; Costa, Ana Catarina; Fernandes-Platzgummer, Ana; Farinha, José Paulo; Rodrigues, Carlos A. V.; et al. "Scalable Production of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Under Serum-/Xeno-Free Conditions in a Microcarrier-Based Bioreactor Culture System". Frontiers in Cell and Developmental Biology 8 (2020): http://dx.doi.org/10.3389/fcell.2020.553444.
  25. Cavaco, Marco; Pérez-Peinado, Clara; Valle, Javier; Silva, Rúben D. M.; Correia, João D. G.; Andreu, David; Castanho, Miguel A. R. B.; Neves, Vera. "To What Extent Do Fluorophores Bias the Biological Activity of Peptides? A Practical Approach Using Membrane-Active Peptides as Models". Frontiers in Bioengineering and Biotechnology 8 (2020): http://dx.doi.org/10.3389/fbioe.2020.552035.
  26. Skalska, Julia; Andrade, Vitor M.; Cena, Gabrielle L.; Harvey, Peta J.; Gaspar, Diana; Mello, Érica O.; Henriques, Sónia T.; et al. "Synthesis, Structure, and Activity of the Antifungal Plant Defensin PvD1". Journal of Medicinal Chemistry 63 17 (2020): 9391-9402. http://dx.doi.org/10.1021/acs.jmedchem.0c00543.
  27. Belo, Rita F.; Martins, Margarida L. F.; Shvachiy, Liana; Costa-Coelho, Tiago; de Almeida-Borlido, Carolina; Fonseca-Gomes, João; Neves, Vera; et al. "The Neuroprotective Action of Amidated-Kyotorphin on Amyloid ß Peptide-Induced Alzheimer’s Disease Pathophysiology". Frontiers in Pharmacology 11 (2020): http://dx.doi.org/10.3389/fphar.2020.00985.
  28. Sousa, David Cordeiro; Leal, Inês; Moreira, Susana; do Vale, Sónia; Silva-Herdade, Ana S.; Aguiar, Patrício; Dionísio, Patrícia; et al. "Retinal Vascular Reactivity in Type 1 Diabetes Patients Without Retinopathy Using Optical Coherence Tomography Angiography". Investigative Opthalmology & Visual Science 61 6 (2020): 49. http://dx.doi.org/10.1167/iovs.61.6.49.
  29. Marco Cavaco; Javier Valle; Ruben da Silva; João D.G. Correia; Miguel A. R. B Castanho; David Andreu; Vera Neves. "DPepH3, an Improved Peptide Shuttle for Receptor-independent Transport Across the Blood-Brain Barrier". Current Pharmaceutical Design 26 13 (2020): 1495-1506. https://doi.org/10.2174/1381612826666200213094556.
  30. Aroeira, Rita I.; A.R.B. Castanho, Miguel. "Can citation metrics predict the true impact of scientific papers?". The FEBS Journal (2020): http://dx.doi.org/10.1111/febs.15255.
  31. Conceição, Katia; de Cena, Gabrielle L.; da Silva, Verônica A.; de Oliveira Neto, Xisto Antonio; de Andrade, Vitor Martins; Tada, Dayane Batista; Richardson, Michael; et al. "Design of bioactive peptides derived from CART sequence isolated from the toadfish Thalassophryne nattereri". 3 Biotech 10 4 (2020): http://dx.doi.org/10.1007/s13205-020-2151-4.
  32. Castanho, Miguel. "Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?". Pharmaceutics (2020): http://dx.doi.org/10.3390/pharmaceutics12010062.
  33. Aroeira, Rita I.; Castanho, Miguel A. R. B.. "Pharmaceutical Innovations: The Grand Challenges Ahead". Frontiers in Medical Technology 1 (2020): http://dx.doi.org/10.3389/fmedt.2019.00003.
    Acesso aberto • Publicado • 10.3389/fmedt.2019.00003
  34. Tiago N. Figueira; Marco M. Domingues; Françoise Illien; Iris Cadima-Couto; Toni Todorovski; David Andreu; Sandrine Sagan; et al. "Enfuvirtide-Protoporphyrin IX Dual-Loaded Liposomes: In Vitro Evidence of Synergy against HIV-1 Entry into Cells". ACS Infectious Diseases (2019): https://doi.org/10.1021/acsinfecdis.9b00285.
    Acesso aberto • Aceite para publicação • 10.1021/acsinfecdis.9b00285
  35. Martins de Andrade, Vitor; Bardají, Eduard; Heras, Montserrat; Ramu, Vasanthakumar G.; Junqueira, Juliana Campos; Diane dos Santos, Jéssica; Castanho, Miguel A.R.B.; Conceição, Katia. "Antifungal and anti-biofilm activity of designed derivatives from kyotorphin". Fungal Biology (2019): http://dx.doi.org/10.1016/j.funbio.2019.12.002.
  36. Grégoire J.-B. Philippe; Diana Gaspar; Caibin Sheng; Yen-Hua Huang; Aurélie H. Benfield; Nicholas D. Condon; Joachim Weidmann; et al. "Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix–Loop–Helix Peptides with Cell Penetrating and Tumor Suppressor Properties". ACS Chemical Biology (2019): https://doi.org/10.1021/acschembio.9b00593.
  37. Santa-Maria, Ana R.; Walter, Fruzsina R.; Valkai, Sándor; Brás, Ana Rita; Mészáros, Mária; Kincses, András; Klepe, Adrián; et al. "Lidocaine turns the surface charge of biological membranes more positive and changes the permeability of blood-brain barrier culture models". Biochimica et Biophysica Acta (BBA) - Biomembranes 1861 9 (2019): 1579-1591. http://dx.doi.org/10.1016/j.bbamem.2019.07.008.
  38. Pérez-Peinado, Clara; Dias, Susana A.; Mendonça, Diogo A.; Castanho, Miguel A.R.B.; Veiga, Ana S.; Andreu, David. "Structural determinants conferring unusual long life in human serum to rattlesnake-derived antimicrobial peptide Ctn[15-34]". Journal of Peptide Science 25 8 (2019): http://dx.doi.org/10.1002/psc.3195.
  39. Thais H. Costa Petrin; Valmir Fadel; Danubia B. Martins; Susana A. Dias; Ana Cruz; Luciana Marciano Sergio; Manoel Arcisio-Miranda; Miguel A. R. B. Castanho; Marcia P. dos Santos Cabrera. "Synthesis and Characterization of Peptide–Chitosan Conjugates (PepChis) with Lipid Bilayer Affinity and Antibacterial Activity". Biomacromolecules (2019): https://doi.org/10.1021/acs.biomac.9b00501.
  40. David Cordeiro Sousa; Inês Leal; Susana Moreira; Sónia do Vale; Ana R. Silva-Herdade; Patrícia Dionísio; Miguel A. R. B. Castanho; Luís Abegão Pinto; Carlos Marques-Neves. "Optical coherence tomography angiography study of the retinal vascular plexuses in type 1 diabetes without retinopathy". Eye (2019): https://doi.org/10.1038/s41433-019-0513-0.
  41. Sousa, David Cordeiro; Leal, Inês; Moreira, Susana; do Vale, Sónia; Silva-Herdade, Ana S.; Aguiar, Patrício; Dionísio, Patrícia; et al. "A Protocol to Evaluate Retinal Vascular Response Using Optical Coherence Tomography Angiography". Frontiers in Neuroscience 13 (2019): http://dx.doi.org/10.3389/fnins.2019.00566.
  42. Pinto, Sandra N; Dias, Susana A; Cruz, Ana F; Mil-Homens, Dalila; Fernandes, Fabio; Valle, Javier; Andreu, David; et al. "The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms". Journal of Antimicrobial Chemotherapy 74 9 (2019): 2617-2625. http://dx.doi.org/10.1093/jac/dkz223.
  43. Julia Skalska; Filipa D. Oliveira; Tiago N. Figueira; Érica O. Mello; Valdirene M. Gomes; Grant McNaughton-Smith; Miguel A. R. B. Castanho; Diana Gaspar. "Plant defensin PvD1 modulates the membrane composition of breast tumour-derived exosomes". Nanoscale (2019): https://doi.org/10.1039/C9NR07843F.
  44. Tiago N. Figueira; Diogo A. Mendonça; Diana Gaspar; Manuel N. Melo; Anne Moscona; Matteo Porotto; Miguel A. R. B. Castanho; Ana Salomé Veiga. "Structure–Stability–Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles". ACS Nano 12 10 (2018): 9855-9865. https://doi.org/10.1021/acsnano.8b01422.
  45. Avram, Speranta; Milac, Adina-Luminita; Borcan, Livia-Cristina; Mihailescu, Dan; Borcan, Florin; Castanho, Miguel. "Designing of Artificial Peptides for an Improved Antiviral Activity". Current Proteomics 15 4 (2018): 258-266. http://dx.doi.org/10.2174/1570164615666180409151111.
  46. Cavaco, Marco; Castanho, Miguel A. R. B.; Neves, Vera. "Peptibodies: An elegant solution for a long-standing problem". Peptide Science 110 1 (2018): e23095. http://dx.doi.org/10.1002/bip.23095.
  47. Pérez-Peinado, Clara; Dias, Susana Almeida; Domingues, Marco M.; Benfield, Aurélie H.; Freire, João Miguel; Rádis-Baptista, Gandhi; Gaspar, Diana; et al. "Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15–34), antimicrobial peptides from rattlesnake venom". Journal of Biological Chemistry 293 5 (2017): 1536-1549. http://dx.doi.org/10.1074/jbc.ra117.000125.
  48. Neves-Coelho, Sara; Eleutério, Rute; Enguita, Francisco; Neves, Vera; Castanho, Miguel. "A New Noncanonical Anionic Peptide That Translocates a Cellular Blood–Brain Barrier Model". Molecules 22 10 (2017): 1753. http://dx.doi.org/10.3390/molecules22101753.
  49. Juliana Perazzo; Carla Lima; Montserrat Heras; Eduard Bardají; Mônica Lopes-Ferreira; Miguel Castanho. "Neuropeptide Kyotorphin Impacts on Lipopolysaccharide-Induced Glucocorticoid-Mediated Inflammatory Response. A Molecular Link to Nociception, Neuroprotection, and Anti-Inflammatory Action". ACS Chemical Neuroscience (2017): https://doi.org/10.1021%2Facschemneuro.7b00007.
  50. Figueira, Tiago N.; Freire, João M.; Cunha-Santos, Catarina; Heras, Montserrat; Gonçalves, João; Moscona, Anne; Porotto, Matteo; Salomé Veiga, Ana; Castanho, Miguel A. R. B.. "Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance". Scientific Reports 7 1 (2017): http://dx.doi.org/10.1038/srep45647.
  51. Cruz-Oliveira, Christine; Almeida, Andreza F.; Freire, João M.; Caruso, Marjolly B.; Morando, Maria A.; Ferreira, Vivian N. S.; Assunção-Miranda, Iranaia; et al. "Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX". Antimicrobial Agents and Chemotherapy 61 6 (2017): http://dx.doi.org/10.1128/aac.00053-17.
  52. Neves, Vera; Aires-da-Silva, Frederico; Morais, Maurício; Gano, Lurdes; Ribeiro, Elisabete; Pinto, Antónia; Aguiar, Sandra; et al. "Novel Peptides Derived from Dengue Virus Capsid Protein Translocate Reversibly the Blood–Brain Barrier through a Receptor-Free Mechanism". ACS Chemical Biology 12 5 (2017): 1257-1268. http://dx.doi.org/10.1021/acschembio.7b00087.
  53. Freire, João Miguel; Rego de Figueiredo, Inês; Valle, Javier; Veiga, Ana Salomé; Andreu, David; Enguita, Francisco J.; Castanho, Miguel A.R.B.. "siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model". Journal of Controlled Release 245 (2017): 127-136. http://dx.doi.org/10.1016/j.jconrel.2016.11.027.
  54. Figueira, T.N.; Palermo, L.M.; Veiga, A.S.; Huey, D.; Alabi, C.A.; Santos, N.C.; Welsch, J.C.; et al. "In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence". Journal of Virology 91 1 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85008214612&partnerID=MN8TOARS.
  55. Dias, S.A.; Freire, J.M.; Pérez-Peinado, C.; Domingues, M.M.; Gaspar, D.; Vale, N.; Gomes, P.; et al. "New potent membrane-targeting antibacterial peptides from viral capsid proteins". Frontiers in Microbiology 8 MAY (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85019698304&partnerID=MN8TOARS.
  56. Tiago N. Figueira; Filipa D. Oliveira; Inês Almeida; Érica O. Mello; Valdirene M. Gomes; Miguel A. R. B. Castanho; Diana Gaspar; et al. "Challenging metastatic breast cancer with the natural defensin PvD1". Nanoscale 9 43 (2017): 16887-16899. https://doi.org/10.1039/C7NR05872A.
  57. Santos, Raquel; Gomes, Diana; Macedo, Hermes; Barros, Diogo; Tibério, Catarina; Veiga, Ana Salomé; Tavares, Luís; Castanho, Miguel; Oliveira, Manuela. "Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers Staphylococcus aureus isolates". Journal of Medical Microbiology 65 10 (2016): 1092-1099. http://dx.doi.org/10.1099/jmm.0.000329.
  58. Perazzo, Juliana; Lopes-Ferreira, Mônica; Sá Santos, Sónia; Serrano, Isa; Pinto, Antónia; Lima, Carla; Bardaji, Eduard; et al. "Endothelium-Mediated Action of Analogues of the Endogenous Neuropeptide Kyotorphin (Tyrosil-Arginine): Mechanistic Insights from Permeation and Effects on Microcirculation". ACS Chemical Neuroscience 7 8 (2016): 1130-1140. http://dx.doi.org/10.1021/acschemneuro.6b00099.
  59. Sá Santos, Sónia; Santos, Sara M.; Pinto, Antónia R. T.; Ramu, Vasanthakumar G.; Heras, Montserrat; Bardaji, Eduard; Tavares, Isaura; Castanho, Miguel A. R. B.. "Amidated and Ibuprofen-Conjugated Kyotorphins Promote Neuronal Rescue and Memory Recovery in Cerebral Hypoperfusion Dementia Model". Frontiers in Aging Neuroscience 8 (2016): http://dx.doi.org/10.3389/fnagi.2016.00001.
  60. Freire, João Miguel; Almeida Dias, Susana; Flores, Luís; Veiga, Ana Salomé; Castanho, Miguel A.R.B.; Freire, J.M.; Dias, S.A.; et al. "Mining viral proteins for antimicrobial and cell-penetrating drug delivery peptides". Bioinformatics 31 14 (2015): 2252-2256. http://dx.doi.org/10.1093/bioinformatics/btv131.
  61. Freire, João Miguel; Gaspar, Diana; de la Torre, Beatriz Garcia; Veiga, Ana Salomé; Andreu, David; Castanho, Miguel A.R.B.. "Monitoring antibacterial permeabilization in real time using time-resolved flow cytometry". Biochimica et Biophysica Acta (BBA) - Biomembranes 1848 2 (2015): 554-560. http://dx.doi.org/10.1016/j.bbamem.2014.11.001.
  62. Gaspar, Diana; Freire, João M.; Pacheco, Teresa R.; Barata, João T.; Castanho, Miguel A.R.B.. "Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1853 2 (2015): 308-316. http://dx.doi.org/10.1016/j.bbamcr.2014.11.006.
  63. Serrano, Isa D.; Ramu, Vasanthakumar G.; Pinto, Antónia R. T.; Freire, João M.; Tavares, Isaura; Heras, Montserrat; Bardaji, Eduard R.; Castanho, Miguel A. R. B.. "Correlation between membrane translocation and analgesic efficacy in kyotorphin derivatives". Biopolymers 104 1 (2015): 1-10. http://dx.doi.org/10.1002/bip.22580.
  64. Freire, J.M.; Gaspar, D.; Veiga, A.S.; Castanho, M.A.R.B.. "Shifting gear in antimicrobial and anticancer peptides biophysical studies: From vesicles to cells". Journal of Peptide Science (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84922513384&partnerID=MN8TOARS.
  65. Cruz-Oliveira, C.; Freire, J.M.; Conceição, T.M.; Higa, L.M.; Castanho, M.A.; Da Poian, A.T.. "Receptors and routes of dengue virus entry into the host cells". FEMS microbiology reviews 39 2 (2015): 155-170. http://www.scopus.com/inward/record.url?eid=2-s2.0-84928213004&partnerID=MN8TOARS.
  66. Freire, J.M.; Santos, N.C.; Veiga, A.S.; Da Poian, A.T.; Castanho, M.A.R.B.. "Rethinking the capsid proteins of enveloped viruses: Multifunctionality from genome packaging to genome transfection". FEBS Journal 282 12 (2015): 2267-2278. http://www.scopus.com/inward/record.url?eid=2-s2.0-84935858831&partnerID=MN8TOARS.
  67. Santos, Sara; Castanho, Miguel. "The Use of Visual Analog Scales to Compare Pain Between Patients With Alzheimer’s Disease and Patients Without Any Known Neurodegenerative Disease and Their Caregivers". American Journal of Alzheimer's Disease & Other Dementiasr 29 4 (2013): 320-325. http://dx.doi.org/10.1177/1533317513517046.
  68. Freire, João Miguel; Veiga, Ana Salomé; Conceição, Thaís M.; Kowalczyk, Wioleta; Mohana-Borges, Ronaldo; Andreu, David; Santos, Nuno C.; Da Poian, Andrea T.; Castanho, Miguel A. R. B.. "Intracellular Nucleic Acid Delivery by the Supercharged Dengue Virus Capsid Protein". PLoS ONE 8 12 (2013): e81450. http://dx.doi.org/10.1371/journal.pone.0081450.
  69. Freire, João M.; Veiga, Ana Salomé; Rego de Figueiredo, Inês; de la Torre, Beatriz G.; Santos, Nuno C.; Andreu, David; Da Poian, Andrea T.; Castanho, Miguel A. R. B.. "Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action". FEBS Journal 281 1 (2013): 191-215. http://dx.doi.org/10.1111/febs.12587.
  70. Franquelim, Henri G.; Gaspar, Diana; Veiga, A. Salomé; Santos, Nuno C.; Castanho, Miguel A.R.B.. "Decoding distinct membrane interactions of HIV-1 fusion inhibitors using a combined atomic force and fluorescence microscopy approach". Biochimica et Biophysica Acta (BBA) - Biomembranes 1828 8 (2013): 1777-1785. http://dx.doi.org/10.1016/j.bbamem.2013.03.006.
  71. Santos, Sara Matos; Garcia-Nimo, Laura; Sá Santos, Sónia; Tavares, Isaura; Cocho, José A.; Castanho, Miguel A. R. B.. "Neuropeptide Kyotorphin (Tyrosyl-Arginine) has Decreased Levels in the Cerebro-Spinal Fluid of Alzheimer’s Disease Patients: Potential Diagnostic and Pharmacological Implications". Frontiers in Aging Neuroscience 5 (2013): http://dx.doi.org/10.3389/fnagi.2013.00068.
  72. Gaspar, Diana; Veiga, A. Salomé; Castanho, Miguel A. R. B.. "From antimicrobial to anticancer peptides. A review". Frontiers in Microbiology 4 (2013): http://dx.doi.org/10.3389/fmicb.2013.00294.
  73. Veiga, Ana Salomé; Sinthuvanich, Chomdao; Gaspar, Diana; Franquelim, Henri G.; Castanho, Miguel A.R.B.; Schneider, Joel P.. "Arginine-rich self-assembling peptides as potent antibacterial gels". Biomaterials 33 35 (2012): 8907-8916. http://dx.doi.org/10.1016/j.biomaterials.2012.08.046.
  74. Gaspar, Diana; Veiga, Ana Salomé; Sinthuvanich, Chomdao; Schneider, Joel P.; Castanho, Miguel A. R. B.. "Anticancer Peptide SVS-1: Efficacy Precedes Membrane Neutralization". Biochemistry 51 32 (2012): 6263-6265. http://dx.doi.org/10.1021/bi300836r.
  75. Ribeiro, Marta M. B.; Domingues, Marco M.; Freire, João M.; Santos, Nuno C.; Castanho, Miguel A. R. B.. "Translocating the blood-brain barrier using electrostatics". Frontiers in Cellular Neuroscience 6 (2012): http://dx.doi.org/10.3389/fncel.2012.00044.
  76. Melo, Manuel N.; Castanho, Miguel A. R. B.. "The Mechanism of Action of Antimicrobial Peptides: Lipid Vesicles vs. Bacteria". Frontiers in Immunology 3 (2012): http://dx.doi.org/10.3389/fimmu.2012.00236.
  77. Melo, Manuel N.; Ferre, Rafael; Feliu, Lídia; Bardají, Eduard; Planas, Marta; Castanho, Miguel A. R. B.. "Prediction of Antibacterial Activity from Physicochemical Properties of Antimicrobial Peptides". PLoS ONE 6 12 (2011): e28549. http://dx.doi.org/10.1371/journal.pone.0028549.
  78. Ribeiro, Marta M. B.; Pinto, Antónia R. T.; Domingues, Marco M.; Serrano, Isa; Heras, Montserrat; Bardaji, Eduard R.; Tavares, Isaura; Castanho, Miguel A.. "Chemical Conjugation of the Neuropeptide Kyotorphin and Ibuprofen Enhances Brain Targeting and Analgesia". Molecular Pharmaceutics 8 5 (2011): 1929-1940. http://dx.doi.org/10.1021/mp2003016.
  79. Ribeiro, MMB; Pinto, A; Pinto, M; Heras, M; Martins, I; Correia, A; Bardaji, E; Tavares, I; Castanho, M. "Inhibition of nociceptive responses after systemic administration of amidated kyotorphin". British Journal of Pharmacology 163 5 (2011): 964-973. http://dx.doi.org/10.1111/j.1476-5381.2011.01290.x.
  80. Freire, João M.; Domingues, Marco M.; Matos, Joana; Melo, Manuel N.; Veiga, Ana Salomé; Santos, Nuno C.; Castanho, Miguel A. R. B.. "Using zeta-potential measurements to quantify peptide partition to lipid membranes". European Biophysics Journal 40 4 (2011): 481-487. http://dx.doi.org/10.1007/s00249-010-0661-4.
  81. Franquelim, H.G.; Chiantia, S.; Veiga, A.S.; Santos, N.C.; Schwille, P.; Castanho, M.A.R.B.; Franquelim HG; et al. "Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes". AIDS 25 4 (2011): 419-428. http://www.scopus.com/inward/record.url?eid=2-s2.0-79951514918&partnerID=MN8TOARS.
  82. Franquelim, H.G.; De-Sousa, F.F.; Veiga, A.S.; Santos, N.C.; Castanho, M.A.R.B.. "Cationic liposomes are possible drug-delivery systems for HIV fusion inhibitor sifuvirtide". Soft Matter 7 23 (2011): 11089-11092. http://www.scopus.com/inward/record.url?eid=2-s2.0-81355123272&partnerID=MN8TOARS.
  83. Ribeiro, Marta M.B.; Melo, Manuel N.; Serrano, Isa D.; Santos, Nuno C.; Castanho, Miguel A.R.B.. "Drug–lipid interaction evaluation: why a 19th century solution?". Trends in Pharmacological Sciences 31 10 (2010): 449-454. http://dx.doi.org/10.1016/j.tips.2010.06.007.
  84. Alves CS; Melo MN; Franquelim HG; Ferre R; Planas M; Feliu L; Bardají E; et al. "Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR.". Journal of Biological Chemistry 285 36 (2010): 27536-27544. http://europepmc.org/abstract/med/20566635.
  85. Franquelim, Henri G.; Veiga, A. Salomé; Weissmüller, G.; Santos, Nuno C.; Castanho, Miguel A.R.B.. "Unravelling the molecular basis of the selectivity of the HIV-1 fusion inhibitor sifuvirtide towards phosphatidylcholine-rich rigid membranes". Biochimica et Biophysica Acta (BBA) - Biomembranes 1798 6 (2010): 1234-1243. http://dx.doi.org/10.1016/j.bbamem.2010.02.010.
    doi: 10.1016/j.bbamem.2010.02.010
  86. Matos, Pedro M.; Castanho, Miguel A. R. B.; Santos, Nuno C.. "HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes". PLoS ONE 5 3 (2010): e9830. http://dx.doi.org/10.1371/journal.pone.0009830.
  87. Ferre, Rafael; Melo, Manuel N.; Correia, Ana D.; Feliu, Lidia; Bardají, Eduard; Planas, Marta; Castanho, Miguel. "Synergistic Effects of the Membrane Actions of Cecropin-Melittin Antimicrobial Hybrid Peptide BP100". Biophysical Journal 96 5 (2009): 1815-1827. http://dx.doi.org/10.1016/j.bpj.2008.11.053.
  88. Melo, Manuel N.; Ferre, Rafael; Castanho, Miguel A. R. B.. "Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations". Nature Reviews Microbiology 7 3 (2009): 245-250. http://dx.doi.org/10.1038/nrmicro2095.
  89. Franquelim, Henri G.; Loura, Luís M. S.; Santos, Nuno C.; Castanho, Miguel A. R. B.. "Sifuvirtide Screens Rigid Membrane Surfaces. Establishment of a Correlation between Efficacy and Membrane Domain Selectivity among HIV Fusion Inhibitor Peptides". Journal of the American Chemical Society 130 19 (2008): 6215-6223. http://dx.doi.org/10.1021/ja711247n.
  90. Stauffer, Fausto; Nuno Melo, Manuel; Carneiro, Fabiana A.; Sousa, Francisco J. R.; Juliano, Maria A.; Juliano, Luiz; Mohana-Borges, Ronaldo; Da Poian, Andrea T.; Castanho, Miguel A. R. B.. "Interaction between dengue virus fusion peptide and lipid bilayers depends on peptide clustering". Molecular Membrane Biology 25 2 (2008): 128-138. http://dx.doi.org/10.1080/09687680701633091.
  91. Henriques, Sónia Troeira; Castanho, Miguel A. R. B.. "Translocation or membrane disintegration? Implication of peptide–membrane interactions in pep-1 activity". Journal of Peptide Science 14 4 (2008): 482-487. http://dx.doi.org/10.1002/psc.1003.
  92. Ribeiro, Marta M. B.; Franquelim, Henri G.; Castanho, Miguel A. R. B.; Veiga, Ana Salomé. "Molecular interaction studies of peptides using steady-state fluorescence intensity. Static (de)quenching revisited". Journal of Peptide Science 14 4 (2008): 401-406. http://dx.doi.org/10.1002/psc.939.
  93. Domingues, Marco M.; Santiago, Patrícia S.; Castanho, Miguel A. R. B.; Santos, Nuno C.. "What can light scattering spectroscopy do for membrane-active peptide studies?". Journal of Peptide Science 14 4 (2008): 394-400. http://dx.doi.org/10.1002/psc.1007.
  94. Melo, Manuel Nuno; Castanho, Miguel A.R.B.. "Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturation". Biochimica et Biophysica Acta (BBA) - Biomembranes 1768 5 (2007): 1277-1290. http://dx.doi.org/10.1016/j.bbamem.2007.02.005.
  95. Troeira Henriques, Sónia; Quintas, Alexandre; Bagatolli, Luis A.; Homblé, Fabrice; Castanho, Miguel A.R.B.. "Energy-independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1". Molecular Membrane Biology 24 4 (2007): 282-293. http://dx.doi.org/10.1080/09687860601142936.
  96. Henriques, S.T.; Melo, M.N.; Castanho, M.A.R.B.; Henriques ST; Melo MN; Castanho MA. "Cell-penetrating peptides and antimicrobial peptides: How different are they?". Biochemical Journal 399 1 (2006): 1-7. http://www.scopus.com/inward/record.url?eid=2-s2.0-33749385780&partnerID=MN8TOARS.
  97. Castanho, Miguel A.R.B.; Fernandes, Miguel X.. "Lipid membrane-induced optimization for ligand–receptor docking: recent tools and insights for the “membrane catalysis” model". European Biophysics Journal 35 2 (2005): 92-103. http://dx.doi.org/10.1007/s00249-005-0007-9.
  98. Veiga, A. Salomé; Santos, Nuno C.; Loura, Luís M. S.; Fedorov, Aleksandre; Castanho, Miguel A. R. B.. "HIV Fusion Inhibitor Peptide T-1249 Is Able To Insert or Adsorb to Lipidic Bilayers. Putative Correlation with Improved Efficiency". Journal of the American Chemical Society 126 45 (2004): 14758-14763. http://dx.doi.org/10.1021/ja0459882.
  99. Santos, Nuno C.; Prieto, Manuel; Castanho, Miguel A.R.B.. "Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods". Biochimica et Biophysica Acta (BBA) - Biomembranes 1612 2 (2003): 123-135. http://dx.doi.org/10.1016/s0005-2736(03)00112-3.
  100. Lopes, S.; Castanho, M.A.R.B.. "Revealing the orientation of nystatin and amphotericin B in lipidic multilayers by UV-Vis linear dichroism". Journal of Physical Chemistry B 106 29 (2002): 7278-7282. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037173871&partnerID=MN8TOARS.
  101. Fernandes, M.X.; García De La Torre, J.; Castanho, M.A.R.B.; Fernandes MX; García de la Torre J; Castanho MA. "Joint determination by Brownian dynamics and fluorescence quenching of the in-depth location profile of biomolecules in membranes". Analytical Biochemistry 307 1 (2002): 1-12. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036667912&partnerID=MN8TOARS.
  102. Castanho, M.A.R.B.; Santos, N.C.; Loura, L.M.S.. "Separating the turbidity spectra of vesicles from the absorption spectra of membrane probes and other chromophores". European Biophysics Journal 26 3 (1997): 253-259. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030823194&partnerID=MN8TOARS.
  103. Castanho, M.A.; Brown, W.; Prieto, M.J.. "Rod-like cholesterol micelles in aqueous solution studied using polarized and depolarized dynamic light scattering". Biophysical Journal 63 6 (1992): 1455-1461. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027078034&partnerID=MN8TOARS.
Artigo em revista (magazine)
  1. Castanho, Miguel. "Why we can't resist sugar - what science says?", Visão Saúde, 2019, http://www.pt.cision.com/cp2013/ClippingDetails.aspx?id=8a74f51c-b7f0-4e1a-b37f-417c2ec160f9&analises=1.
  1. Da Poian, Andrea T.; Castanho, Miguel A. R. B.. Integrative Human Biochemistry. Springer International Publishing. 2021.
Poster em conferência
  1. Castanho, Miguel. "“Blood-based biomarker for Alzheimer’s disease.” Santos I., Neves V., Castanho M. iMed conference® 7.0, Lisbon, 17-20th September 2015.". 2015.
Recurso online
  1. Castanho, Miguel. "What's hidden in viral proteins? Lessons from Dengue virus capsid", - CEDOC Seminars. 2019. https://www.youtube.com/watch?v=rqkwU60p2l8.

Propriedade Intelectual

  2. A.R.B. Castanho, Miguel. 2021. "Antibody Molecules and Peptide Delivery Systems for Use in Alzheimer's Disease and Related Disorders". Estados Unidos.
  3. Castanho, Miguel. 2020. "Antibody molecules and peptide delivery systems for use in Alzheimer's disease or related disorders". Estados Unidos.
  4. Castanho, Miguel. 2020. "C-X-C motif chemokine receptor 4 antagonist".
  5. Castanho, Miguel. 2019. "Peptide compounds for reducing side effects of CB1 receptor agonists".
  6. Castanho, Miguel. 2016. "Antibody Molecules And Peptide Delivery Systems For Use In Alzheimer’s Disease And Related Disorders".


Outra produção
  1. "Targeting brain metastases with a peptide conjugate". Cavaco M, Pérez-Peinado C, Gaspar D, Andreu D, Castanho MARB, Neves V. FEBS OPEN BIO 9: 372.. 2019. Castanho, Miguel.
  2. "Linking Structure, Stability and Function in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles". Figueira TN, Mendonça DA, Gaspar D, Melo MN, Moscona A, Porotto M, Castanho MARB, Veiga AS. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 48: S158-S158.. 2019. Castanho, Miguel.
  3. "Effect of pH on the influenza fusion peptide structure and activity: A constant-pH molecular dynamics approach". Lousa D, Pinto ART, Campos SRR, Baptista AM, Veiga AS, Castanho MARB, Soares CM. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 48: S47-S47.. 2019. Castanho, Miguel.
  4. "The efficacy of designed anti-measles virus peptides depends on the stability of self-assembled clusters". Mendonça DA, Figueira TF, Melo M, Harder O, Niewiesk S, Moscona A, Porotto M, Castanho MARB, Veiga AS. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 48: S81-S81.. 2019. Castanho, Miguel.
  5. "Anticancer activity of a novel cell -penetrating peptide, vCPP2319, and its interaction with breast cancer cells' derived exosomes". Oliveira FD, Figueira TN, Napoleao P, Andreu D, Castanho MARB, Gaspar D. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 48: S116-S116.. 2019. Castanho, Miguel.
  6. "Insights into the mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms". Pinto SN, Dias SA, Cruz AF, Mil-Homens D, Fernandes F, Valle J, Andreu D, Prieto M, Castanho MARB, Coutinho A, Veiga AS. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS 48: S117-S117.. 2019. Castanho, Miguel.
  7. "Effects of Diabetes on Microcirculation in Non-Ocular Tissues: Insights into Hemodynamic Alterations in Diabetic Retinopathy". Silva-Herdade AS, Saldanha C, Ha N, Hou I, Castanho MARB, Roy S. Journal of Vascular Research 56, 101.. 2019. Castanho, Miguel.
  8. "Novel mechanism of action of natural plant defensin PvD1 involves a modulatory effect of CD63 and CD9 expression level in breast cancer cells derived exosomes". Skalska J, Oliveira FD, Figueira TN, Mello EO, Gomes VM, Castanho MARB, Gaspar D. FEBS OPEN BIO 9: 325.. 2019. Castanho, Miguel.
  9. "Dengue Virus Capsid Protein Interacts Specifically with Very Low-Density Lipoproteins". Faustino, André F.; Carvalho, Filomena A.; Martins, Ivo C.; Castanho, Miguel A.R. B.; Mohana-Borges, Ronaldo; Almeida, Fabio C.L.; Da Poian, Andrea T.; Santos, Nuno C.. Biophysical Journal 106 (2): 388a. http://dx.doi.org/10.1016/j.bpj.2013.11.2194.. 2014. Castanho, Miguel.
  10. "The Dengue Virus Capsid Protein Inhibitor Peptide Pep14-23 becomes Alpha-Helical upon Binding to Negative Lipids". Faustino, André F.; Artilheiro, Vanessa; Castanho, Miguel A.R.B.; Almeida, Fábio;Da Poian, Andrea T.; Santos, Nuno C.; Martins, Ivo C.. Biophysical Journal 104 (2): 536a. http://dx.doi.org/10.1016/j.bpj.2012.11.2970.. 2013. Castanho, Miguel.
  11. "Dengue Virus Capsid Protein Binding to Lipid Droplets and its Inhibition.towards a New Drug Target". Carvalho, Filomena A.; Martins, Ivo C.; Carneiro, Fabiana A.; Assunção-Miranda,Iranaia; Faustino, André F.; Castanho, Miguel; Mohana-Borges, Ronaldo; et al. Biophysical Journal 104 (2): 415a. http://dx.doi.org/10.1016/j.bpj.2012.11.2313.. 2013. Castanho, Miguel.
  12. "Decoding Distinct Membrane Interactions of HIV-1 Inhibitors Enfuvirtideand T-1249 using Atomic Force Microscopy Combined with FluorescenceMethodologies". Franquelim, Henri G.; Veiga, A. Salomé; Santos, Nuno C.; Castanho, Miguel A.. Biophysical Journal 102 (3): 490a. http://dx.doi.org/10.1016/j.bpj.2011.11.2685.. 2012. Castanho, Miguel.
  13. "Short Stories - onAntimicrobial Peptides that are Too Short to Span the Membrane". Ulrich, Anne S.; Heidenreich, Nico; Wadhwani, Parvesh; Reichert, Johannes;Strandberg, Erik; Misievicz, Julia; Afonin, Sergii; et al. Biophysical Journal 102 (3): 616a. http://dx.doi.org/10.1016/j.bpj.2011.11.3358.. 2012. Castanho, Miguel.
  14. "Relating Molecular-Level Events with Bacterial Killing by AntimicrobialPeptides". Melo, Manuel N.; Ferre, Rafael; Alves, Carla; Castanho, Miguel A.R.B.. Biophysical Journal 102 (3): 91a-91a. http://dx.doi.org/10.1016/j.bpj.2011.11.518.. 2012. Castanho, Miguel.
  15. "Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 SynergisticallyPotentiates Peptide-Membrane Interaction". Matos, Pedro M.; Hollmann, Axel; Castanho, Miguel A.; Santos, Nuno C. Biophysical Journal 102 (3): 490a-490a. http://dx.doi.org/10.1016/j.bpj.2011.11.2684.. 2012. Castanho, Miguel.
  16. "rBPI21 Causes(HEMI)Fusion and Leakage of Membranes and Promotes Massive Lipopolysaccharide Aggregation". Domingues, Marco; Castanho, Miguel; Santos, Nuno C. Biophysical Journal 100 (3): 495a-495a. http://dx.doi.org/10.1016/j.bpj.2010.12.2901.. 2011. Castanho, Miguel.
  17. "Characterization of the Interaction of the Dengue Virus Capsid Protein withLipid Droplets". Martins, Ivo C.; Carneiro, Fabiana A.; Mohana-Borges, Ronaldo; Faustino, André;Pereira, Renata M.; Carvalho, Filomena A.; Castanho, Miguel A.; et al.. Biophysical Journal 100 (3): 403a-404a. http://dx.doi.org/10.1016/j.bpj.2010.12.2396.. 2011. Castanho, Miguel.
  18. "Human Erythrocytes And Mononuclear Leukocytes Are Capable Of Concentrating HIV-1 Fusion Inhibitor Peptides In Their Membranes". Matos, Pedro M.; Castanho, Miguel A.R.B.; Santos, Nuno C.. Biophysical Journal 96 (3):157a-157a. http://dx.doi.org/10.1016/j.bpj.2008.12.715.. 2009. Castanho, Miguel.

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2021/06/14 'Pursuing Innovative Peptide Drugs with Biophysical Approaches: Why, What, What for?' - Opening Plenary Lecture. 7th International Iberian Biophysics Congress
Iberian Biophysical Societies (Coimbra, Portugal)
2021/04/09 “Diffusion-lysis coupling of antimicrobial peptides in biofilms of S. aureus.” - Keynote speaker M Castanho, keynote speaker.
University Graz (Graz, Áustria)

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação)
Instituição / Organização
2020/09/05 - Atual “Nanomedicine – tiny tools to beat the giant cancer challenge.” Session of ESOF2020 – Euroscience Open Forum (European Commission), Speaker and session chairman. Turin, Italy. (2020/09/05)
Congresso (Coorganizador)
Commissione Europea Rappresentanza in Italia, Itália

Arbitragem científica em conferência

Nome da conferência Local da conferência
2022/07/09 - Atual “The Biochemistry Global Summit 2022” FEBS, IUBMB, and PABMB joint congress - Chairman of the FEBS, IUBMB, and PABMB.

Entrevista (jornal / revista)

Descrição da atividade Jornal / Forum
2019 Interview in Canal Saúde+: Raio X.

Entrevista / Programa (rádio / tv)

Programa Tema
2020/02/10 - Atual "A synthesis of what we know about viruses". - "Antena 2 Ciência"
2019/10/14 - Atual What we already know about viruses and what we don't know yet
2019/10/07 - Atual Fighting viruses that attack the brain, a project by biochemist Miguel Castanho that received a European fund of 4.2 million euros
2019/03/05 - Atual HIV. Advances are positive but it is "premature" to speak in healing


2023 Biophysical Society, USA; Ambassador
2022 Biochemical Society UK; Ambassador
2022 EIC; Ambassador
2019 Scientific Award Universidade de Lisboa / Caixa Geral de Depósitos 2018 in the scientific area of Biomedical Sciences.
2019 Pedagogical Merit Award of Prof. Doutor J. Gomes-Pedro
Universidade de Lisboa Faculdade de Medicina, Portugal

Outra distinção

2020 Personality of the year (for outreach and science communication)
2020 Ranked among the top 1.1% of most cited authors in Biophysics according to a science-wide author database of standardized citation indicators (PLoS Biol 18: e3000918; 2020. doi.org/10.1371/journal.pbio.3000918)
2019 Appointed Chief Editor of Pharmaceutical Innovation, a speciality journal of Frontiers in Medical Technology, Springer Nature Publishing Group. (https://www.frontiersin.org/journals/medical-technology/sections/pharmaceutical-innovation)
2015 Grünenthal Dor Award, Clinical Research
Fundação Grünenthal, Portugal
2014 Leonidas Zervas award
European Peptide Society, Espanha
2012 International Local Embassador
Biochemical Society UK, Reino Unido
2012 Specially invited researcher on Medical Biochemistry (Postgraduation and Outreach Programs)
Universidade Federal do Rio de Janeiro, Brasil
2011 Biophytsicist in profile - Miguel Castanho
2010 I2P - Ideas to Products, European competition (2nd Best Technology)
2009 Grünenthal Dor Award
2005 Prof José Luis Champalimaud award
2004 Vicente de Seabra Medal
2004 Dr. José Luis Champalimaud Award
Direcção-Geral da Saúde, Portugal
1996 Programa Gulbenkian de Estímulo à Investigação, Área de Fotofísica e Fotoquímica.
Fundação Calouste Gulbenkian, Portugal